Payment overview · 2025
General Payments
$129.10
8 reported records · 6 companies
Healthcare provider profile · identity verified
Robert Leonard Deucher, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · SOUTHERN PINES, NC · NPI 1922042662
Verified facts
What the public records show
CMS Open Payments records show Robert Leonard Deucher, M.D. received $129.10 in general payments during 2025 across 8 reported records.
Radius Health, Inc. accounted for 35.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Nuedexta, Ozempic, Rybelsus.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PROLIA as an associated drug or biological on 20867 records involving 11744 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Prolia by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 163 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Rybelsus by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Nuedexta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Radius Health, Inc. | Unresolved — no canonical attribution shown | $45.50 | 35.2% | 3 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $19.99 | 15.5% | 1 | 2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $18.19 | 14.1% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $16.69 | 12.9% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $14.84 | 11.5% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $13.89 | 10.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $129.10 | 8 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Tymlos Normalized: tymlos |
Drug | Radius Health, Inc. | $45.50 | 3 | 2025 |
Source payment records
|
|||||
| NUEDEXTA Normalized: nuedexta |
Drug | Otsuka America Pharmaceutical, Inc. | $19.99 | 1 | 2025 |
Source payment records
|
|||||
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.19 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $16.69 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $14.84 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $13.89 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $13.89 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| NUEDEXTA nuedexta |
2025 | Nuedexta | 2024 | 30 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 163 | exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 22 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | PROLIA open payments reported associated product |
CMS Open Payments — General Payments 20867 supporting records · 11744 recipient NPIs · example record 1226874448 |
Prolia · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
163 | 30 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
22 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 551 | 157 |
| Atorvastatin Calcium | Atorvastatin Calcium | 458 | 132 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 371 | 105 |
| Omeprazole | Omeprazole | 353 | 96 |
| Gabapentin | Gabapentin | 348 | 81 |
| Levothyroxine Sodium | Levothyroxine Sodium | 327 | 88 |
| Lisinopril | Lisinopril | 324 | 96 |
| Metoprolol Succinate | Metoprolol Succinate | 295 | 95 |
| Losartan Potassium | Losartan Potassium | 274 | 78 |
| Pantoprazole Sodium | Pantoprazole Sodium | 262 | 85 |
| Furosemide | Furosemide | 210 | 75 |
| Eliquis | Apixaban | 204 | 50 |
| Mirtazapine | Mirtazapine | 203 | 59 |
| Metformin Hcl | Metformin Hcl | 197 | 51 |
| Carvedilol | Carvedilol | 177 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 168 | 54 |
| Ozempic | Semaglutide | 163 | 30 |
| Potassium Chloride | Potassium Chloride | 159 | 56 |
| Oxycodone Hcl | Oxycodone Hcl | 155 | 27 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 150 | 25 |
| Jardiance | Empagliflozin | 150 | 39 |
| Alprazolam | Alprazolam | 147 | 39 |
| Sertraline Hcl | Sertraline Hcl | 143 | 37 |
| Lorazepam | Lorazepam | 132 | 22 |
| Celecoxib | Celecoxib | 128 | 34 |
| Duloxetine Hcl | Duloxetine Hcl | 121 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 118 | 37 |
| Tramadol Hcl | Tramadol Hcl | 117 | 36 |
| Glimepiride | Glimepiride | 111 | 29 |
| Nifedipine Er | Nifedipine | 110 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 108 | 28 |
| Trazodone Hcl | Trazodone Hcl | 105 | 33 |
| Meloxicam | Meloxicam | 103 | 43 |
| Hydrochlorothiazide | Hydrochlorothiazide | 100 | 30 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 97 | 26 |
| Spironolactone | Spironolactone | 96 | 29 |
| Escitalopram Oxalate | Escitalopram Oxalate | 95 | 24 |
| Simvastatin | Simvastatin | 93 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 92 | 30 |
| Azithromycin | Azithromycin | 91 | 74 |
| Quetiapine Fumarate | Quetiapine Fumarate | 90 | 24 |
| Atenolol | Atenolol | 89 | 20 |
| Hydralazine Hcl | Hydralazine Hcl | 89 | 28 |
| Metoprolol Tartrate | Metoprolol Tartrate | 89 | 32 |
| Pregabalin | Pregabalin | 89 | 16 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 85 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 84 | 32 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 83 | 57 |
| Allopurinol | Allopurinol | 82 | 24 |
| Famotidine | Famotidine | 82 | 24 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 80 | 24 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 79 | 23 |
| Prednisone | Prednisone | 77 | 45 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 73 | 22 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 68 | 21 |
| Fluoxetine Hcl | Fluoxetine Hcl | 66 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 64 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 64 | 20 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 62 | 14 |
| Donepezil Hcl | Donepezil Hcl | 59 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 53 | 16 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 52 | 47 |
| Ondansetron Odt | Ondansetron | 52 | 21 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 51 | 15 |
| Ezetimibe | Ezetimibe | 51 | 17 |
| Metformin Hcl Er | Metformin Hcl | 51 | 15 |
| Linzess | Linaclotide | 50 | 16 |
| Nystatin | Nystatin | 50 | 25 |
| Tizanidine Hcl | Tizanidine Hcl | 50 | 29 |
| Cefdinir | Cefdinir | 48 | 42 |
| Fluconazole | Fluconazole | 48 | 26 |
| Synthroid | Levothyroxine Sodium | 48 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 47 | 27 |
| Buspirone Hcl | Buspirone Hcl | 46 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 44 | 15 |
| Xarelto | Rivaroxaban | 44 | 13 |
| Doxycycline Hyclate | Doxycycline Hyclate | 40 | 33 |
| Citalopram Hbr | Citalopram Hydrobromide | 39 | suppressed |
| Bupropion Xl | Bupropion Hcl | 38 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 38 | 11 |
| Warfarin Sodium | Warfarin Sodium | 37 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 36 | suppressed |
| Memantine Hcl | Memantine Hcl | 35 | 11 |
| Clonazepam | Clonazepam | 34 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 34 | suppressed |
| Cephalexin | Cephalexin | 33 | 23 |
| Dexamethasone | Dexamethasone | 33 | 25 |
| Valsartan | Valsartan | 33 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 32 | 11 |
| Ramipril | Ramipril | 32 | suppressed |
| Amoxicillin | Amoxicillin | 31 | 22 |
| Levetiracetam | Levetiracetam | 31 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 30 | 22 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 30 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 28 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 28 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 28 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 27 | suppressed |
| Colchicine | Colchicine | 27 | 11 |
| Diazepam | Diazepam | 27 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 27 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 27 | suppressed |
| Temazepam | Temazepam | 27 | suppressed |
| Trulicity | Dulaglutide | 27 | suppressed |
| Finasteride | Finasteride | 26 | 11 |
| Nebivolol Hcl | Nebivolol Hcl | 26 | suppressed |
| Sucralfate | Sucralfate | 25 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 24 | suppressed |
| Methylprednisolone | Methylprednisolone | 24 | 20 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 24 | suppressed |
| Topiramate | Topiramate | 24 | suppressed |
| Verapamil Er | Verapamil Hcl | 24 | suppressed |
| Ibuprofen | Ibuprofen | 23 | suppressed |
| Januvia | Sitagliptin Phosphate | 23 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | suppressed |
| Nitroglycerin | Nitroglycerin | 23 | 13 |
| Torsemide | Torsemide | 23 | suppressed |
| Acyclovir | Acyclovir | 22 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 22 | suppressed |
| Rybelsus | Semaglutide | 22 | suppressed |
| Fentanyl | Fentanyl | 21 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 21 | suppressed |
| Primidone | Primidone | 20 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 19 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 19 | suppressed |
| Testosterone | Testosterone | 19 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 19 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 19 | suppressed |
| Carbamazepine | Carbamazepine | 18 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Levofloxacin | Levofloxacin | 18 | 15 |
| Metoclopramide Hcl | Metoclopramide Hcl | 18 | suppressed |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 18 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 18 | suppressed |
| Cartia Xt | Diltiazem Hcl | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | 12 |
| Digoxin | Digoxin | 17 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 17 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Sotalol | Sotalol Hcl | 16 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 15 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | 12 |
| Paxlovid | Nirmatrelvir/Ritonavir | 15 | 15 |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Irbesartan | Irbesartan | 14 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 14 | suppressed |
| Oxycontin | Oxycodone Hcl | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Repatha Sureclick | Evolocumab | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Baclofen | Baclofen | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 13 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Prolia | Denosumab | 13 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 13 | suppressed |
| Scopolamine | Scopolamine | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Belbuca | Buprenorphine Hcl | 12 | suppressed |
| Calcium Acetate | Calcium Acetate | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 12 | suppressed |
| Dexilant | Dexlansoprazole | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Letrozole | Letrozole | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Prozac | Fluoxetine Hcl | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 12 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 11 | suppressed |
| Armour Thyroid | Thyroid,pork | 11 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $129.10 · 8 records | Radius Health, Inc. | EVENITY, NUEDEXTA, Ozempic, Rybelsus, The Cologuard Plus Collection Kit, Tymlos, XIFAXAN | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Nuedexta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Amgen Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error